EGFR—TKI在非小细胞肺癌中的耐药机制及治疗研究进展(4)
[16] Zakowski M F，Ladanyi M，Kris M G.EGFR mutations in small-cell lung cancers in patients who have never smoked[J].The New England Journal of Medicine，2006，355(2)：213-215.[17] Popat S，Wotherspoon A，Nutting C M，et al.Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma[J].Lung Cancer (Amsterdam ......
您现在查看是摘要页，全文长 2196 字符。